Market Cap 7.06B
Revenue (ttm) 0.00
Net Income (ttm) -190.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -1.38
Volume 795,700
Avg Vol 1,052,620
Day's Range N/A - N/A
Shares Out 77.83M
Stochastic %K 29%
Beta 0.39
Analysts Strong Sell
Price Target $121.25

Company Profile

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporat...

Industry: Biotechnology
Sector: Healthcare
Phone: 33 1 53 83 09 63
Address:
7-11 boulevard Haussmann, Paris, France
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 25 at 6:41 AM
$SLS $2.X per share is about $250M in Market Value. This will quadruple to $1B and Still have 2,000% more Upside. ​A Positive P3 Result is worth $20B to Big Pharma all day long. $8.X to $10 in Play Before the P3 Results are announced - followed by a Gap Up into the $40/$50 Range on the Announcement and Given the massive Value, will keep Climbing - Just Like $ABVX Did. Pro tip: When Gps announces a 3x 4x OS Advantage for AML CR2 Patients - Every AML CR1 Patient on the planet, all 35,000 each year will want Gps Treatment. - any Buyer will absolutely include this expanded Market in their Consideration.
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 24 at 10:32 PM
$SLS $2.X per share is about $250M in Market Value. This will quadruple to $1B and Still have 2,000% Upside. ​A Positive P3 Result is worth $20B all day long. $8.X to $10 in Play Before the P3 Results are announced - followed by a Gap Up into the $40/$50 Range on the Announcement and Given the massive Value, will keep Climbing - Just Like $ABVX Did. Pro tip: When Gps announces a 3x 4x OS Advantage for AML CR2 Patients - Every AML CR1 Patient on the planet, all 35,000 each year will want Gps Treatment. - any Buyer will absolutely include this expanded Market in their Consideration.
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 9:46 PM
$ABUS $ABVX $ACAD $ACDC $ACEL 10/10 TO 10/24 LIST Results 🔥 Cycle Trading Signal plugged into AI 🔥
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 24 at 5:46 PM
$SLS $250M Mcap about to Release Top Line FDA Registrational Phase 3 Results - giving GPs the FDA Green light to treat upwards of 25,000 AML Remission Patients and Generate Billions in REAL REVENUE - a $9B TAM - worth every bit of $20B to Big Pharma. Be Holding for when this Gaps Up 500% - 1,000%, ala $ABVX Top Line Results Will Be Announced Any Day Now.
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 24 at 12:59 AM
$SLS Nov 2023, 105 Phase 3 Trial Patients were Enrolled - Next week it'll be 24 months - 2 years. March 2024 ALL 128 patients were Enrolled - 20 Months. Dr. Jamy was Asked Point Blank, What is the Longest OS you see for patients on BAT in CR2, not getting transplant .... he says Median OS on Aza + VEN is Dismal and you won't See Survival Past 12 months --- -- +/- 60 Control ARM Patient EVENTS - AND WE'RE STILL NOT AT 80!!! Says It all - this what Dr. Jamy will tell the Market Next week. -- A positive Phase 3 Registrational Result is a FDA Green Light to Generate Billions in Revenue - Real Revenue H2 2026 Revenue that must and Will Be Fairly Valued by the "market". Be Holding. As many as You Can. What happened at $ABVX is the Perfect Example of what Phase 3 trial Results can do for the Value of a Small Bio.
0 · Reply
Heypentaco
Heypentaco Oct. 24 at 12:20 AM
$SLS Im getting the feeling here this will pull an $ABVX move. Nobody gets to chase.
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 23 at 4:08 PM
$SLS $ABVX Next week SLS Launches - it is Inevitable. 10X to 100X - ROI on the TABLE. A Positive p3 result .636 or better and GPS gets a FDA Green Light to Generate Billions in REAL Revenue - worth $20B to Big Pharma, that will be Fairly Valued and Reflected in the Share Price. Either we See the top line, OR the KOL's and Co, tell the ENTIRE Market NOW PAYING ATTENTION, Gps is GOLDEN - and Results Could be ANNOUNCED at any time. Any Day Now may seem like an eternity to the short Penny Flips, scraping their knuckles for pennies, @mrtunity but ANY DAY NOW and within just 1 or 2 months is a Very Short time for the 142 Institutional Funds Invested here. $XBI $TSLA $BTC.X
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 23 at 1:56 PM
$SLS $ABVX If, IF we have yet to see the P3 Top Line Results by Next weeks KOL, what do you think these Dr's who treat 15% of the actual P3 Patients are going to Say? They are already on RECORD STATING (BAT) Best Available Treatments for Control Patients are Toxic, and MOS is DISMAL, NOT DURABLE, Extremely Poor - Do You Think they are Back to Say Something Different? And it Now a year Later, 10 months Post Interim, they will be Telling ALL THE MARKET, Including the 142 Institutional FUNDS Currently Interested, GPS is GettingFDA Approval and RESULTS are NOW IMMINENT - OFFICIALLY IMMINENT - and Worth $20B + to Big Pharma.
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 22 at 7:29 PM
$SLS $ABVX If, IF we have yet to see the P3 Top Line Results by Next weeks KOL, what do you think these Dr's who treat 15% of the actual P3 Patients are going to Say? We already have them on RECORD STATING (BAT) Best Available Treatments for Control Patients are Toxic, and MOS is DISMAL, NOT DURABLE, Extremely Poor - Do You Think they are Back to Say Something Different? And it Now a year Later, 10 months Post Interim, they will be Telling ALL THE MARKET, GPS is GettingFDA Approval and RESULTS are NOW IMMINENT - OFFICIALLY IMMINENT - and Worth $20B + to Big Pharma.
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 22 at 5:26 PM
$SLS Can't Believe October is Nearly Over 10/22 Top Line Phase 3 Results, 5 Years in the making will BE ANNOUNCED - ANY DAY NOW - they are Inevitable - and EVERYONE Knows GPS is Golden. Aza VEN - BAT is a Failure. The only real question is what the Share Price will be when the P3 Results are announced. A positive P3 result, is a Fda green light to generate Literal Billions in Real Revenue, - Billions in Real Revenue that big Pharma will be Bidding for - Institutional Funds Know, BR Knows, GPS will Generate Billions in actual revenue that must and Will be Reconciled and fairly reflected in this baby bio Share Price. This $265M in rigged Market Value is about to be 5.2B and Climbing The fact Gps Immunotherapy will Generate Billions actual Revenue in 2026 Must and Will Be Reflected in the Share Price. Something Similar to What happened at $ABVX - will be happening here....
0 · Reply
Latest News on ABVX
Why Is Abivax Stock Trading Higher On Monday?

Oct 6, 2025, 11:05 AM EDT - 19 days ago

Why Is Abivax Stock Trading Higher On Monday?


Abivax Presents First Half 2025 Financial Results

Sep 8, 2025, 4:00 PM EDT - 6 weeks ago

Abivax Presents First Half 2025 Financial Results


How Hedge Funds Won Big on an Obscure Drugmaker

Aug 30, 2025, 5:30 AM EDT - 2 months ago

How Hedge Funds Won Big on an Obscure Drugmaker


2 Logical Mid-Cap Biotech Buyout Targets

Aug 27, 2025, 12:50 PM EDT - 2 months ago

2 Logical Mid-Cap Biotech Buyout Targets

MLTX


Abivax Announces Closing of $747.5 Million Public Offering

Jul 28, 2025, 4:15 PM EDT - 3 months ago

Abivax Announces Closing of $747.5 Million Public Offering


Abivax Announces Launch of Public Offering

Jul 23, 2025, 4:15 PM EDT - 3 months ago

Abivax Announces Launch of Public Offering


Abivax Presents First Quarter 2025 Financial Results

Jun 2, 2025, 4:00 PM EDT - 5 months ago

Abivax Presents First Quarter 2025 Financial Results


Abivax Announces Full Year 2024 Financial Results

Mar 24, 2025, 3:30 AM EDT - 7 months ago

Abivax Announces Full Year 2024 Financial Results


Abivax Publishes 2025 Financial Calendar

Jan 28, 2025, 2:30 AM EST - 9 months ago

Abivax Publishes 2025 Financial Calendar


Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment

Jan 9, 2025, 11:35 AM EST - 10 months ago

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment


Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

Nov 19, 2024, 4:30 PM EST - 1 year ago

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq


Abivax presents third quarter 2024 key financial information

Nov 14, 2024, 4:01 PM EST - 1 year ago

Abivax presents third quarter 2024 key financial information


Abivax presents first-half 2024 financial results

Sep 9, 2024, 4:01 PM EDT - 1 year ago

Abivax presents first-half 2024 financial results


Abivax Provides Operational and Key Program Update

Jul 15, 2024, 4:00 PM EDT - 1 year ago

Abivax Provides Operational and Key Program Update


Abivax reports 2023 financial results and operational update

Apr 2, 2024, 2:30 AM EDT - 1 year ago

Abivax reports 2023 financial results and operational update


Citi Appointed as Depositary Bank for Abivax SA's ADR Program

Oct 26, 2023, 4:00 AM EDT - 2 years ago

Citi Appointed as Depositary Bank for Abivax SA's ADR Program


Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 25 at 6:41 AM
$SLS $2.X per share is about $250M in Market Value. This will quadruple to $1B and Still have 2,000% more Upside. ​A Positive P3 Result is worth $20B to Big Pharma all day long. $8.X to $10 in Play Before the P3 Results are announced - followed by a Gap Up into the $40/$50 Range on the Announcement and Given the massive Value, will keep Climbing - Just Like $ABVX Did. Pro tip: When Gps announces a 3x 4x OS Advantage for AML CR2 Patients - Every AML CR1 Patient on the planet, all 35,000 each year will want Gps Treatment. - any Buyer will absolutely include this expanded Market in their Consideration.
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 24 at 10:32 PM
$SLS $2.X per share is about $250M in Market Value. This will quadruple to $1B and Still have 2,000% Upside. ​A Positive P3 Result is worth $20B all day long. $8.X to $10 in Play Before the P3 Results are announced - followed by a Gap Up into the $40/$50 Range on the Announcement and Given the massive Value, will keep Climbing - Just Like $ABVX Did. Pro tip: When Gps announces a 3x 4x OS Advantage for AML CR2 Patients - Every AML CR1 Patient on the planet, all 35,000 each year will want Gps Treatment. - any Buyer will absolutely include this expanded Market in their Consideration.
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 9:46 PM
$ABUS $ABVX $ACAD $ACDC $ACEL 10/10 TO 10/24 LIST Results 🔥 Cycle Trading Signal plugged into AI 🔥
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 24 at 5:46 PM
$SLS $250M Mcap about to Release Top Line FDA Registrational Phase 3 Results - giving GPs the FDA Green light to treat upwards of 25,000 AML Remission Patients and Generate Billions in REAL REVENUE - a $9B TAM - worth every bit of $20B to Big Pharma. Be Holding for when this Gaps Up 500% - 1,000%, ala $ABVX Top Line Results Will Be Announced Any Day Now.
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 24 at 12:59 AM
$SLS Nov 2023, 105 Phase 3 Trial Patients were Enrolled - Next week it'll be 24 months - 2 years. March 2024 ALL 128 patients were Enrolled - 20 Months. Dr. Jamy was Asked Point Blank, What is the Longest OS you see for patients on BAT in CR2, not getting transplant .... he says Median OS on Aza + VEN is Dismal and you won't See Survival Past 12 months --- -- +/- 60 Control ARM Patient EVENTS - AND WE'RE STILL NOT AT 80!!! Says It all - this what Dr. Jamy will tell the Market Next week. -- A positive Phase 3 Registrational Result is a FDA Green Light to Generate Billions in Revenue - Real Revenue H2 2026 Revenue that must and Will Be Fairly Valued by the "market". Be Holding. As many as You Can. What happened at $ABVX is the Perfect Example of what Phase 3 trial Results can do for the Value of a Small Bio.
0 · Reply
Heypentaco
Heypentaco Oct. 24 at 12:20 AM
$SLS Im getting the feeling here this will pull an $ABVX move. Nobody gets to chase.
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 23 at 4:08 PM
$SLS $ABVX Next week SLS Launches - it is Inevitable. 10X to 100X - ROI on the TABLE. A Positive p3 result .636 or better and GPS gets a FDA Green Light to Generate Billions in REAL Revenue - worth $20B to Big Pharma, that will be Fairly Valued and Reflected in the Share Price. Either we See the top line, OR the KOL's and Co, tell the ENTIRE Market NOW PAYING ATTENTION, Gps is GOLDEN - and Results Could be ANNOUNCED at any time. Any Day Now may seem like an eternity to the short Penny Flips, scraping their knuckles for pennies, @mrtunity but ANY DAY NOW and within just 1 or 2 months is a Very Short time for the 142 Institutional Funds Invested here. $XBI $TSLA $BTC.X
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 23 at 1:56 PM
$SLS $ABVX If, IF we have yet to see the P3 Top Line Results by Next weeks KOL, what do you think these Dr's who treat 15% of the actual P3 Patients are going to Say? They are already on RECORD STATING (BAT) Best Available Treatments for Control Patients are Toxic, and MOS is DISMAL, NOT DURABLE, Extremely Poor - Do You Think they are Back to Say Something Different? And it Now a year Later, 10 months Post Interim, they will be Telling ALL THE MARKET, Including the 142 Institutional FUNDS Currently Interested, GPS is GettingFDA Approval and RESULTS are NOW IMMINENT - OFFICIALLY IMMINENT - and Worth $20B + to Big Pharma.
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 22 at 7:29 PM
$SLS $ABVX If, IF we have yet to see the P3 Top Line Results by Next weeks KOL, what do you think these Dr's who treat 15% of the actual P3 Patients are going to Say? We already have them on RECORD STATING (BAT) Best Available Treatments for Control Patients are Toxic, and MOS is DISMAL, NOT DURABLE, Extremely Poor - Do You Think they are Back to Say Something Different? And it Now a year Later, 10 months Post Interim, they will be Telling ALL THE MARKET, GPS is GettingFDA Approval and RESULTS are NOW IMMINENT - OFFICIALLY IMMINENT - and Worth $20B + to Big Pharma.
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 22 at 5:26 PM
$SLS Can't Believe October is Nearly Over 10/22 Top Line Phase 3 Results, 5 Years in the making will BE ANNOUNCED - ANY DAY NOW - they are Inevitable - and EVERYONE Knows GPS is Golden. Aza VEN - BAT is a Failure. The only real question is what the Share Price will be when the P3 Results are announced. A positive P3 result, is a Fda green light to generate Literal Billions in Real Revenue, - Billions in Real Revenue that big Pharma will be Bidding for - Institutional Funds Know, BR Knows, GPS will Generate Billions in actual revenue that must and Will be Reconciled and fairly reflected in this baby bio Share Price. This $265M in rigged Market Value is about to be 5.2B and Climbing The fact Gps Immunotherapy will Generate Billions actual Revenue in 2026 Must and Will Be Reflected in the Share Price. Something Similar to What happened at $ABVX - will be happening here....
0 · Reply
kshonstocks
kshonstocks Oct. 22 at 9:22 AM
$ABVX great piece on biotech m and a https://x.com/seedy19tron/status/1980541552976924689
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 21 at 6:07 PM
$SLS Just the First AML CR2 Indication - the Setting for the Ongoing REGAL Phase 3 trial, has a $5B TAM. Top Line Results will be announced - ANY DAY NOW. The Current $250M Rigged Market Value - will Instantly be worth Literal Billions. @nasfact Gps Value is not Some Amorphous down the road thing -- A positive Phase 3 Registrational Result is a FDA Green Light to Generate Billions in Revenue - Real Revenue H2 2026 Revenue that must and Will Be Fairly Valued by the "market". https://www.reddit.com/r/sellasLifescience/comments/1o01k9l/what_is_gps_worth_a_working_thread/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button Be Holding. As many as You Can. What happened at $ABVX is the Perfect Example of what Phase 3 trial Results can do for the Value of a Small Bio. $XBI $BTC.X $TSLA
0 · Reply
CrispDry
CrispDry Oct. 19 at 7:28 PM
$ABVX $12B should be attainable? Talking $150 roughly
0 · Reply
Quantumup
Quantumup Oct. 17 at 7:30 PM
Citi⬆️ $PTGX's PT to $96 from $72 and kept it at a Buy rating after updating its model and said Rusfertide's De-Risked Profile Supports Upside $JNJ $TAK $BMY $ABVX Citi additionally said:
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 17 at 7:23 PM
$SLS $270M market cap about to release Phase 3 FDA registrational results worth - every nickel of $20B to Big Pharma ... Oct 29 will be en fuego. $20B is not hyperbole, ask your favorite AI what a $9B TAM is worth to bp. SLS will Double 2x ahead of the P3 TopLine announcement to catch up to that Massive Value. This Market Manipulated Rigged Share Price is the Investment Opportunity of a Lifetime. $ABVX
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Oct. 17 at 6:02 PM
$SLS I think right now, this late Friday Afternoon trading Session is offering the Last Discounted Shares. "Join us as we dive into Groundbreaking advancements" - "Has turned challenges into triumphs " - "Built Something" - CEO is telling Everyone GPS is Golden, its a done Deal. - Aza Ven is Toxic, and doesn't lead to durable OS. - Gps has Prevented Relapse and Extended Survival in EVERY SINGLE PREVIOUS TRIAL - It is Gps, Gps is the reason patients were living 2 fold longer than what was required for approval -- VEN AZA, (BAT) for Control patients has now FAILED, 3 Phase 3 AML Trials. $2.11 Will Be $42.11 and climbing - later this month - very similar to the $ABVX P3 Action.
1 · Reply
BanCrupt
BanCrupt Oct. 17 at 11:46 AM
$ABVX someone on X said ABVX was acting like a safe haven stock and honestly i'm coming around to this idea
2 · Reply
MrMagician
MrMagician Oct. 16 at 5:44 PM
$SLS I'm not saying this will be the next $ABVX but if you look into what they're treating, you'll see why this is a truly special team. Both GPS and SLS009 address high unmet needs where no cures exist.
2 · Reply
Sellasgps24BAT9
Sellasgps24BAT9 Oct. 16 at 5:32 PM
$ABVX $SLS Same Trading pattern as ABVX before the trading halt and re open over $60.00 and now $98.00. GL every one ☝️ This is it. 🙏✌️
0 · Reply
RunicOG
RunicOG Oct. 15 at 6:54 PM
$ABVX cheap
0 · Reply
macdub8
macdub8 Oct. 15 at 4:40 PM
$IXHL honestly i went through this exact same thing on $ABVX for months and months..until one day. Boom. Patience
0 · Reply
ManBullBear2020
ManBullBear2020 Oct. 15 at 3:28 PM
$ABVX $SLS This guy gets it Don’t get shook
1 · Reply